Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3. (Q40681705)
Jump to navigation
Jump to search
scientific article published on September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3. |
scientific article published on September 2002 |
Statements
1 reference
Didox (a novel ribonucleotide reductase inhibitor) overcomes Bcl-2 mediated radiation resistance in prostate cancer cell line PC-3. (English)
1 reference
Mohammed S Inayat
1 reference
Damodaran Chendil
1 reference
Mohammed Mohiuddin
1 reference
Howard L Elford
1 reference
Vincent S Gallicchio
1 reference
Mansoor M Ahmed
1 reference
1 September 2002
1 reference
1 reference
Identifiers
1 reference